Skandinaviska Enskilda Banken (SEB)
RGNX icon

Skandinaviska Enskilda Banken (SEB)’s Regenxbio RGNX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,600
Closed -$319K – 1054
2021
Q3 		$319K Buy
+7,600
New +$273K ﹤0.01% 897
2020
Q4 		– Sell
-1,700
Closed -$47K – 1152
2020
Q3 		$47K Hold
1,700
– – ﹤0.01% 971
2020
Q2 		$63K Buy
+1,700
New +$63.4K ﹤0.01% 985

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s RGNX Position: Q4 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Regenxbio (RGNX) in Q4 2021, closing a stake of 7,600 shares — an estimated $319K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in RGNX in Q2 2020 and held it in 3 quarters. The position peaked at $319K in Q3 2021. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Regenxbio position as of Q4 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 7,600 Regenxbio shares in Q4 2021, an estimated $319K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Regenxbio in Q2 2020 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Regenxbio position peaked at $319K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2021, filed 10 Feb 2022.